1. Home
  2. BEEM vs LITS Comparison

BEEM vs LITS Comparison

Compare BEEM & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.31

Market Cap

39.3M

Sector

Technology

ML Signal

HOLD

LITS

Lite Strategy Inc.

HOLD

Current Price

$0.75

Market Cap

44.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
LITS
Founded
2006
2000
Country
United States
United States
Employees
220
4
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
44.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BEEM
LITS
Price
$1.31
$0.75
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
489.9K
556.6K
Earning Date
04-09-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$0.77
52 Week High
$4.04
$3.03

Technical Indicators

Market Signals
Indicator
BEEM
LITS
Relative Strength Index (RSI) 32.45 24.61
Support Level N/A N/A
Resistance Level $1.66 $1.23
Average True Range (ATR) 0.09 0.07
MACD -0.02 -0.03
Stochastic Oscillator 8.22 3.81

Price Performance

Historical Comparison
BEEM
LITS

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: